Cite
HARVARD Citation
Becherini, C. et al. (n.d.). PO-1096 Safety of concurrent TDM-1 and radiotherapy for patients with residual HER2-positive breast cancer. Radiotherapy and oncology. pp. S912-S913. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Becherini, C. et al. (n.d.). PO-1096 Safety of concurrent TDM-1 and radiotherapy for patients with residual HER2-positive breast cancer. Radiotherapy and oncology. pp. S912-S913. [Online].